3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Triple Negative Breast Neoplasms
2
Ovarian Neoplasms
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Nonhematologic Malignancies
2
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Somatostatinoma
1
Sarcoma, Synovial
1
Sarcoma
1
Recurrent Lung Squamous Cell Carcinoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Non-hematologic Malignancy
1
Neurofibrosarcoma
1
Neoplasm Metastasis
1
Metastatic Castration-Resistant Prostate Cancer
1
Meningeal Neoplasms
1
Lymphoma
1
Liver Neoplasms
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hematologic Neoplasms
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Interventions
Temozolomide
53
Bevacizumab
33
Radiotherapy
27
Radiation
12
Erlotinib Hydrochloride
12
Radiotherapy, Intensity-Modulated
8
Radiotherapy, Conformal
8
Irinotecan
6
Vorinostat
5
Sorafenib
5
Sirolimus
5
temsirolimus
4
Magnetic Resonance Spectroscopy
4
Immunoglobulin G
4
Disulfides
4
Carmustine
4
veliparib
3
plerixafor
3
carmustine, poliferprosan 20 drug combination
3
Radiosurgery
3
Everolimus
3
Dasatinib
3
Bortezomib
3
vandetanib
2
tandutinib
2
sargramostim
2
poly ICLC
2
pembrolizumab
2
pazopanib
2
ferric pyrophosphate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gliosarcoma
×
sapanisertib
×
Clear all
No trials found.